Department of Medicine 5 – Haematology and Oncology

Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease (2023) Al Malki MM, London K, Baez J, Akahoshi Y, Hogan WJ, Etra A, Choe H, et al. Journal article The utility of biomarkers in acute GVHD prognostication (2023) Spyrou N, Akahoshi Y, Ayuk F, Holler E, Choe H, Etra A, Hogan WJ, et al. Journal article Identification and characterization of T-cell receptors with therapeutic potential showing conserved specificity against all SARS-CoV 2 strains (2023) Reimann H, Moosmann C, Schober K, Lang V, Verhagen J, Zeun J, Mackensen A, et al. Journal article Incidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHD (2023) Akahoshi Y, Spyrou N, Hogan WJ, Ayuk F, DeFilipp Z, Weber D, Choe HK, et al. Journal article Inferior Outcomes of EU Versus US Patients Treated with CD19 CAR-T for Relapsed/Refractory Large B-cell Lymphoma: Association with Differences in Tumor Burden, Systemic Inflammation, Bridging Therapy Utilization, and CAR-T Product Use (2023) Bücklein V, Perez A, Rejeski K, Iacoboni G, Jurinovic V, Holtick U, Penack O, et al. Journal article Targeted inhibition of protein synthesis renders cancer cells vulnerable to apoptosis by unfolded protein response (2023) Gsottberger F, Meier C, Ammon AM, Parker S, Wendland K, George R, Petkovic S, et al. Journal article Impact of trisomy 19 on outcome according to genetic makeup in patients with acute myeloid leukemia (2023) Kayser S, Martínez-Cuadrón D, Rodriguez-Veiga R, Hänel M, Tormo M, Schäfer-Eckart K, Botella C, et al. Journal article Isolated late metastasis from testicular seminoma presenting as a parotid gland mass: Case report and review of the literature (2023) Künzel J, Agaimy A, Krause S, Vieth M, Alexiou C Journal article Large case-control study indicates no association of KIR genotype and risk of developing acute myeloid leukemia (2023) Heidenreich F, Falk B, Baldauf H, Massalski C, Schäfer G, Rücker-Braun E, Altmann H, et al. Journal article CD19 CAR T cells are an effective therapy for posttransplant relapse in patients with B-lineage ALL: real-world data from Germany (2023) Bader P, Rossig C, Hutter M, Ayuk FA, Baldus CD, Bücklein VL, Bonig H, et al. Journal article